Exchange: OTC·Updated 11:57 AM EDT

XSNX NovAccess Global Inc

$0.0002
$0.0001
(100.00%)
Today
Mkt Cap$12,330.00
Vol18.00

About XSNX

NovAccess Global, Inc. is a biopharmaceutical company, which engages in the provision of diagnostics, therapeutics in cancer, and neurological diseases and the development of immunotherapies to treat brain tumor patients. The company was founded on February 25, 1997 and is headquartered in New York, NY.
50

Neutral Sentiment

How do you feel about XSNX?

Advertisement|Remove ads.